BioCentury
ARTICLE | Clinical News

Tetmodis tetrabenazine regulatory update

July 13, 2015 7:00 AM UTC

AOP Orphan submitted a regulatory application for Tetmodis tetrabenazine under the EU’s decentralized procedure to treat tardive dyskinesia. The U.K. is the reference member state. The small molecule ...